News

A cultural mediation partnership between the Louvre and L'Oréal on beauty, its practices, its representations, and its role through ages and cultures Paris, November 12, 2024 – The Louvre Museum offers an unprecedented mediation program across its galleries, thanks to the exceptional support of the L’Oréal Groupe.

Solid +6% growth despite turbulences

Commenting on the figures, Nicolas Hieronimus, CEO of L'Oréal, said:

“We delivered solid growth of +6% in the first nine months, well-balanced between value and volume, despite multiple turbulences that have negatively impacted our third quarter.

Global Access to Skin Health Observatory to assess 194 nations’ ability to provide vital skin health services to citizens Today at the Skin Alliance Forum, the Dermatological Beauty division of L’Oréal Groupe and the International League of Dermatological Societies (ILDS) announced a landmark study into the availability and accessibility of dermatological services in 194 countries.

Publication of the components of remuneration of corporate officers made pursuant to the AFEP-MEDEF code of corporate governance for listed companies of December 2022Allocation of performance shares to the Chief Executive Officer by the Board of Directors at its meeting on 10 October 2024Within the scope of the authorisation of the Extraordinary General Meeting of 23 April 2024 (resolution 19), and in accordance with the 2024 remuneration policy approved by the General Meeting of 23 April 2024 (resolution 16), the Board of Directors decided, on 10 October 2024, on the recommendation of the Human Resources and Remuneration Committee, to allocate 16,000 shares, subject to performance conditions assessed over 3 full financial years, to Mr Nicolas Hieronimus, Chief Executive Officer of L’Oréal.

We invite you to explore the Group’s latest Letter to Shareholders.

Discover the interactive versionRead the Letter number 88

On Friday, September 13, 2024, Christophe Babule, Chief Financial Officer of L'Oréal, participated in the sixth edition of the Giverny Forum.

Tri-party agreement will drive biotech innovation via integrated lab-to-market collaboration L’Oréal Groupe today announces a tri-party agreement with biotech innovator, Abolis Biotechnologies and global specialty manufacturer, Evonik, to enable the discovery, development and manufacturing of innovative and sustainable ingredients for beauty products and beyond.

L’Oréal has been recognized for its commitment to diversity, equity and inclusion, securing the fifth position globally in this year’s prestigious FTSE Diversity & Inclusion Index Top 100 companies list.

Every year, L'Oréal's Annual Report offers a deep dive into the heart of our strategy, our commitments, and our ambitions for the future.